Dear Mr. White, We are writing to you to express our concern about the lack of availability in developing countries of the new melt extrusion (Meltrex) formulation of lopinavir/ritonavir (LPV/r), marketed as Kaletra (200/50mg tablets).

More >

A Statement Delivered by Helen O'Neill, Deputy Director of Operations, Médecins Sans Frontières (MSF) at the United Nations Security Council "Arria Formula" meeting

More >